SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001599298-24-000141
Filing Date
2024-09-13
Accepted
2024-09-13 19:29:45
Documents
1
Period of Report
2024-09-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1726270177.html 4  
1 FORM 4 wk-form4_1726270177.xml 4 6205
  Complete submission text file 0001599298-24-000141.txt   7914
Mailing Address 51 ADAM WAY ATHERTON CA 94027
Business Address
Zanganeh Mahkam (Reporting) CIK: 0001507650 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36866 | Film No.: 241299069

Mailing Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025
Business Address 2882 SAND HILL ROAD SUITE 106 MENLO PARK CA 94025 650-460-8308
Summit Therapeutics Inc. (Issuer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)